FDA approves drug for PET imaging of prostate cancer
(HealthDay)—The U.S. Food and Drug Administration approved the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer, the agency ...
Dec 3, 2020
0
3